Two Cases of Lymph Node Metastasis Found in Differentiated, Small-Sized Gastric Adenocarcinomas: Did Tumor Budding Play a Critical Role?
Young Sub LeeYosep ChongKyung-Jin SeoKwangil YimPublished in: Medicina (Kaunas, Lithuania) (2023)
Background: Endoscopic resection (ER) is a minimally invasive therapeutic approach for early gastric cancer (EGC), particularly for cases with a low risk of lymph node metastasis (LNM). Tumor budding (TB) has gained attention as a potential prognostic indicator for LNM in EGC. Case Presentation: We report two cases-a 73-year-old and an 81-year-old male patient-who presented with gastric adenocarcinoma. Both patients had small-sized, differentiated, and intramucosal adenocarcinomas. However, high-grade TBs per high-power field under ×200 magnification at the invasive front and LNMs were found in both cases. Conclusions: These cases conformed to the post-ER observation guidelines of the current treatment protocol, yet demonstrated LNMs. We found that TB could serve as an effective prognostic marker for LNM compared to traditional risk factors. The aim of this study is to re-examine the ability of TB to predict LNM in EGC, thereby providing an impetus for reconsideration and potential revision of the current treatment guidelines for EGC.
Keyphrases
- lymph node metastasis
- squamous cell carcinoma
- high grade
- mycobacterium tuberculosis
- papillary thyroid
- risk factors
- minimally invasive
- end stage renal disease
- randomized controlled trial
- newly diagnosed
- ejection fraction
- estrogen receptor
- ultrasound guided
- low grade
- clinical practice
- human health
- radiation therapy
- combination therapy
- climate change
- replacement therapy
- patient reported
- squamous cell